INmune Bio gets MHRA alignment for 2026 UK drug application
Go back to INmune Bio gets MHRA alignment for 2026 UK drug application| (NASDAQ: INMB) | Delayed: 1.71 -0.13 (7.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.84 | 52 Week High | $ | |||
| Open | $1.80 | 52 Week Low | $ | |||
| Day High | $1.81 | P/E | N/A | |||
| Day Low | $1.71 | EPS | $ | |||
| Volume | 211,004 | |||||

